Vasanth Vedantham, MD, PhD

Cardiologist and electrophysiologist

Dr. Vasanth Vedantham specializes in treating heart rhythm disorders using catheter ablation, pacemaker and defibrillator implantation and antiarrhythmic medications. Conditions he treats include supraventricular tachycardia, atrial fibrillation, atrial flutter, ventricular tachycardia, bradycardia and syncope. He also implants biventricular devices for cardiac resynchronization therapy in patients with heart failure.

Vedantham earned a medical degree and doctorate at Harvard Medical School. He completed an internal medicine residency at the Brigham and Women’s Hospital in Boston, followed by fellowships in cardiovascular medicine and clinical cardiac electrophysiology at UCSF. His research focuses on the molecular biology of the electrical system of the heart, with a goal to make advances in basic cardiovascular science that will lead to improvements in the treatment and prevention of arrhythmias.


Cardiac Electrophysiology and Arrhythmia Service
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143
Phone: (415) 353-2554
Fax: (415) 353-2528

Hours: Monday to Friday
8 a.m. – 5 p.m.

Board Certification

Clinical Cardiac Electrophysio

More about Vasanth Vedantham

Additional Languages



Harvard School of Medicine 2002


Brigham and Women's Hospital, Internal Medicine 2004


UCSF Medical Center, Cardiac Electrophysiology
UCSF Medical Center, Cardiology 2008

Selected Research and Publications

  1. Guo X, Vittinghoff E, Vedantham V, Pletcher MJ, Lee BK. Trends in Hospitalizations for Cardiac Sarcoidosis in the United States, 2005-2011. Circ J. 2017 Sep 13.
  2. Vedantham V, Scheinman MM. Familial inappropriate sinus tachycardia: a new chapter in the story of HCN4 channelopathies. Eur Heart J. 2017 Jan 21; 38(4):289-291.
  3. Nguyen KT, Gladstone RA, Dukes JW, Nazer B, Vittinghoff E, Badhwar N, Vedantham V, Gerstenfeld EP, Lee BK, Lee RJ, Tseng ZH, Olgin JE, Scheinman MM, Marcus GM. The QT Interval as a Noninvasive Marker of Atrial Refractoriness. Pacing Clin Electrophysiol. 2016 Dec; 39(12):1366-1372.
  4. Vedantham V. New Approaches to Biological Pacemakers: Links to Sinoatrial Node Development. Trends Mol Med. 2015 Dec; 21(12):749-61.
  5. Hoffmayer KS, Lee BK, Vedantham V, Bhimani AA, Cakulev IT, Mackall JA, Sahadevan J, Rho RW, Scheinman MM. Response to letter regarding article, "variable clinical features and ablation of manifest nodofascicular/ventricular pathways". Circ Arrhythm Electrophysiol. 2015 Aug; 8(4):995.
  6. Ito H, Kawamura M, Badhwar N, Vedantham V, Tseng ZH, Lee BK, Lee RJ, Marcus GM, Gerstenfeld EP, Scheinman MM. The Effect of Direct Current Stimulation versus T-Wave Shock on Defibrillation Threshold Testing. Pacing Clin Electrophysiol. 2015 Oct; 38(10):1173-80.
  7. Kawamura M, Hsu JC, Vedantham V, Marcus GM, Hsia HH, Gerstenfeld EP, Scheinman MM, Badhwar N. Clinical and electrocardiographic characteristics of idiopathic ventricular arrhythmias with right bundle branch block and superior axis: Comparison of apical crux area and posterior septal left ventricle. Heart Rhythm. 2015 Jun; 12(6):1137-44.
  8. Vedantham V, Galang G, Evangelista M, Deo RC, Srivastava D. RNA sequencing of mouse sinoatrial node reveals an upstream regulatory role for Islet-1 in cardiac pacemaker cells. Circ Res. 2015 Feb 27; 116(5):797-803.
  9. Hoffmayer KS, Lee BK, Vedantham V, Bhimani AA, Cakulev IT, Mackall JA, Sahadevan J, Rho RW, Scheinman MM. Variable clinical features and ablation of manifest nodofascicular/ventricular pathways. Circ Arrhythm Electrophysiol. 2015 Feb; 8(1):117-27.
  10. Kawamura M, Gerstenfeld EP, Vedantham V, Rodrigues DM, Burkhardt JD, Kobayashi Y, Hsia HH, Marcus GM, Marchlinski FE, Scheinman MM, Badhwar N. Idiopathic ventricular arrhythmia originating from the cardiac crux or inferior septum: epicardial idiopathic ventricular arrhythmia. Circ Arrhythm Electrophysiol. 2014 Dec; 7(6):1152-8.
  11. Hua LL, Vedantham V, Barnes RM, Hu J, Robinson AS, Bressan M, Srivastava D, Black BL. Specification of the mouse cardiac conduction system in the absence of Endothelin signaling. Dev Biol. 2014 Sep 15; 393(2):245-254.
  12. Singh DK, Viswanathan MN, Tanel RE, Lee RJ, Lee BK, Marcus GM, Olgin JE, Han F, Vedantham V, Tseng ZH, Pellegrini C, Kawamura M, Gerstenfeld EP, Badhwar N, Scheinman M. His overdrive pacing during supraventricular tachycardia: a novel maneuver for distinguishing atrioventricular nodal reentrant tachycardia from atrioventricular reciprocating tachycardia. Heart Rhythm. 2014 Aug; 11(8):1327-35.
  13. Stepanyan G, Badhwar N, Lee RJ, Marcus GM, Lee BK, Tseng ZH, Vedantham V, Olgin J, Scheinman M, Gerstenfeld EP. Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation. J Interv Card Electrophysiol. 2014 Jun; 40(1):33-8.
  14. Kawamura M, Badhwar N, Vedantham V, Tseng ZH, Lee BK, Lee RJ, Marcus GM, Olgin JE, Gerstenfeld EP, Scheinman MM. Coupling interval dispersion and body mass index are independent predictors of idiopathic premature ventricular complex-induced cardiomyopathy. J Cardiovasc Electrophysiol. 2014 Jul; 25(7):756-62.
  15. Kawamura M, Vedantham V, Dewland TA, Scheinman MM. Incessant long RP tachycardia: what is the mechanism? Heart Rhythm. 2014 May; 11(5):904-6.
  16. Hsu JC, Badhwar N, Gerstenfeld EP, Lee RJ, Mandyam MC, Dewland TA, Imburgia KE, Hoffmayer KS, Vedantham V, Lee BK, Tseng ZH, Scheinman MM, Olgin JE, Marcus GM. Randomized trial of conventional transseptal needle versus radiofrequency energy needle puncture for left atrial access (the TRAVERSE-LA study). J Am Heart Assoc. 2013 Sep 17; 2(5):e000428.
  17. Vedantham V, Jackman WM, Scheinman MM. Unexpected potential following ablation of a right atriofascicular accessory pathway. J Cardiovasc Electrophysiol. 2013 Aug; 24(8):939-41.
  18. Vedantham V, Evangelista M, Huang Y, Srivastava D. Spatiotemporal regulation of an Hcn4 enhancer defines a role for Mef2c and HDACs in cardiac electrical patterning. Dev Biol. 2013 Jan 01; 373(1):149-62.
  19. Scheinman MM, Vedantham V. Ivabradine: a ray of hope for inappropriate sinus tachycardia. J Am Coll Cardiol. 2012 Oct 09; 60(15):1330-2.
  20. Qian L, Huang Y, Spencer CI, Foley A, Vedantham V, Liu L, Conway SJ, Fu JD, Srivastava D. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature. 2012 May 31; 485(7400):593-8.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.